{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:55:41Z","timestamp":1790060141222,"version":"4.0.1"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"NHMRC Project","award":["1100394"],"award-info":[{"award-number":["1100394"]}]},{"name":"ARC Discovery Project","award":["DP170103076"],"award-info":[{"award-number":["DP170103076"]}]},{"name":"Wellcome Trust Senior Fellow in Clinical Sciences","award":["200909"],"award-info":[{"award-number":["200909"]}]},{"name":"NHMRC Centre for Research Excellence in Malaria Elimination","award":["1134989"],"award-info":[{"award-number":["1134989"]}]},{"name":"Victorian Center for Biostatistics","award":["1035261"],"award-info":[{"award-number":["1035261"]}]},{"name":"NHMRC Senior Research Fellow","award":["1104975"],"award-info":[{"award-number":["1104975"]}]},{"name":"NHMRC Centre for Research Excellence in Infectious Disease Modelling to Inform Public Health Policy","award":["1078068"],"award-info":[{"award-number":["1078068"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>\n                    The first line treatment for uncomplicated falciparum malaria is artemisinin-based combination therapy (ACT), which consists of an artemisinin derivative coadministered with a longer-acting partner drug. However, the spread of\n                    <jats:named-content content-type=\"genus-species\">Plasmodium falciparum<\/jats:named-content>\n                    resistant to both artemisinin and its partner drugs poses a major global threat to malaria control activities.\n                  <\/jats:p>","DOI":"10.1128\/aac.01068-18","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T05:56:41Z","timestamp":1534917401000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":46,"title":["Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling"],"prefix":"10.1128","volume":"62","author":[{"given":"Saber","family":"Dini","sequence":"first","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8253-8896","authenticated-orcid":false,"given":"Sophie","family":"Zaloumis","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxing","family":"Cao","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Casuarina, Australia"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya J. I.","family":"Fowkes","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"},{"name":"Burnet Institute, Disease Elimination Program, Public Health, Melbourne, Australia"},{"name":"Department of Epidemiology and Preventative Medicine and Department of Infectious Diseases, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob W.","family":"van der Pluijm","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"McCaw","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"},{"name":"School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia"},{"name":"Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia"},{"name":"Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"World malaria report","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. 2017. World malaria report. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2017\/en\/."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.EI10-0013-2016"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808859"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314981"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70032-0"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30409-1"},{"key":"e_1_3_3_8_2","volume-title":"Artemisinin and artemisinin-based combination therapy resistance","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. 2017. Artemisinin and artemisinin-based combination therapy resistance. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin-resistance-april2017\/en\/."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9647-y"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00487-9"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00835-15"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2304.161872"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1964.tb07437.x"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00177-06"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01172-15"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182099006332"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006113108"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-303"},{"key":"e_1_3_3_19_2","volume-title":"WHO malaria threats map: tracking biological challenges to malaria control and elimination","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. 2018. WHO malaria threats map: tracking biological challenges to malaria control and elimination. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/malaria\/maps\/threats\/."},{"key":"e_1_3_3_20_2","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. 2015. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-017-0141-1"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.2.341"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217452110"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002132"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00618-17"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2017.07.017"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01712-10"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01352-3"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2008.0198"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308256101"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01793-10"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.172398999"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615875114"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00040-06"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-181"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00955-07"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10"},{"key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco WR","year":"1995","unstructured":"Greco WR, Bravo G, Parsons JC. 1995. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47:331\u201385.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.104117"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-011613-135915"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02322290"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-7348.1939.tb06990.x"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb300454t"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565010-00004"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules15031705"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2015.04.007"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780132202"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/10915818809014527"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1081\/BIP-100101978"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0160-5402(90)90058-S"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5193(85)80176-4"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.2307\/1268522"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70010-X"},{"key":"e_1_3_3_54_2","first-page":"631","article-title":"Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients","volume":"73","author":"Kuile FO ter","year":"1995","unstructured":"Kuile FO ter, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, Price R, Chongsuphajaisiddhi T, White NJ. 1995. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ 73:631\u2013642.","journal-title":"Bull World Health Organ"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01068-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01068-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T09:21:13Z","timestamp":1751793673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01068-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1128\/AAC.01068-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.01068-18","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/331850","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"2018-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01068-18"}}